CPRI experienced catastrophic financial deterioration with net losses expanding over 400% to $1.2 billion while simultaneously terminating its planned merger with Tapestry.
The combination of massive loss expansion, 77% decline in stockholders' equity, and failed merger represents a fundamental breakdown in the company's financial position and strategic direction. Investors face a company that has lost most of its equity value while burning through cash with no clear path to recovery following the collapsed Tapestry deal.
CPRI's financials show across-the-board deterioration with net losses ballooning from $229 million to $1.2 billion, operating losses tripling to $752 million, and gross profit declining 15% despite lower interest costs. The balance sheet contracted significantly with stockholders' equity collapsing 77% to just $368 million, total assets shrinking 22%, and cash reserves declining while the company dramatically reduced share buybacks and capital expenditure. This financial profile suggests a company in severe distress with diminished financial flexibility and uncertain viability.
Net income declined 416.2% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Buyback activity reduced 96.3% — capital being redeployed elsewhere or cash conservation underway.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Capex reduced 32.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Total assets contracted 22.1% — asset sales, write-downs, or balance sheet optimization underway.
Current liabilities reduced — improved short-term financial position and working capital health.
Cash decreased 16.6% — monitor burn rate and upcoming capital needs.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →